Found 46 matching trials
Expanded Access Study for Renal Transplant Patients With Envarsus XR ™
N/AOpen label, multi-center, expanded access study for renal transplant patien...
Status
Approved For Marketing
Location
Multiple Locations
Pulse Wave Velocity, Tacrolimus Time in Therapeutic Range and CV in African American Kidney Transplants
PHASE4The primary purpose of this study is to evaluate the pulse wave velocity an...
Status
Active Not Recruiting
Location
Hospital of the University of Pennsylvania
Tacrolimus Versus Mycophenolate for Autoimmune Hepatitis Patients With Incomplete Response on First Line Therapy
PHASE4Rationale: The combination of azathioprine and prednisone is the first-line...
Location
Jeroen Bosch Ziekenhuis
Pilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant Recipients
EARLY_PHASE1This is a pilot study to determine if extended release Envarsus at an optim...
Location
University of Colorado Anschutz Medical Campus
Tacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-release Drugs
PHASE4The goal of this clinical trial is to compare the bioavailability and pract...
Location
University Hospital Aachen, Department of General, Visceral and Transplant Surgery
Evaluation of Anti-rejection Drug, Tacrolimus, in African-Americans With Kidney Transplant
PHASE4In spite of conventional immunosuppression with lymphocyte-depleting induct...
Status
Active Not Recruiting
Location
Multiple Locations
Pharmacokinetic Study of ENVARSUS in Adult De-novo Kidney Transplant Patients
PHASE4Open-label, multicentre, randomized clinical trial to compare the pharmacok...
Location
Nephrology Department Hopital La Cavale Blanche
Bioavailability and Practicability of Envarsus Versus Advagraf in Liver Transplant Recipients
PHASE4Trial participants are randomised within 14 days after liver transplantatio...
Status
Active Not Recruiting
Location
University Hospital Aachen
Extended-Release Tacrolimus Following Liver Transplantation
PHASE4Medications used after transplant to prevent rejection are associated with ...
Location
Univerity of Alberta
PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus
PHASE4The investigators believe that the pharmacological properties of Envarsus®,...
Location
Nantes University Hospital